A Single-center Prospective Measurement of Adherence to Treatment With Tecfidera in Multiple Sclerosis Patients
Phase of Trial: Phase IV
Latest Information Update: 10 Oct 2019
Price : $35 *
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms ADIMS
- 10 Oct 2019 Results published in the Clinical Drug Investigation.
- 17 Mar 2016 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 21 May 2015 Planned End Date changed from 1 Oct 2015 to 1 Jan 2016 as reported by ClinicalTrial.gov record.